Share Print

DiPersio to Receive Clinical Cancer Research Award 

John DiPersio, MD, PhD

Feb. 28, 2014 – John DiPersio, MD, PhD, chief of the Division of Oncology at Washington University School of Medicine, will receive the 19th annual American Association for Cancer Research-Joseph H. Burchenal Memorial Award for Outstanding Achievement in Clinical Cancer Research.

DiPersio, who also is deputy directory of Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine and the Virginia E. and Samuel J. Golman Endowed Professor of Oncology, is being recognized for his achievements in the experimental sequencing of cancer genomes, personalized medicine and stem cell transplantation. He is known internationally for this expertise in T-cell function, stem cell research and acute myelogenous leukemia.

The American Association for Cancer Research will present the award at its annual meeting April 5-9 in San Diego. As part of the honor, DiPersio will give a conference lecture about graft-versus-host disease and graft-versus-leukemia.

DiPersio earned a bachelor's degree in biology from Williams College and a medical degree and doctorate in microbiology from the University of Rochester. After an internship and residency at the University of Texas, Southwestern Medical Center in Dallas, and his first faculty position at the University of California, Los Angeles, he returned to the University of Rochester as the first director of its bone marrow transplant program. In 1994, DiPersio came to the School of Medicine to lead its bone marrow transplant division. At Siteman, DiPersio and other physicians have completed more than 5,000 bone marrow transplants in the past 20 years.

The Burchenal award was established in 1996 to recognize outstanding achievements in clinical cancer research. It is named for the late Joseph H. Burchenal, MD, a pioneering leukemia researcher and a past president of the American Association for Cancer Research.